News
July 7 – With a 90-day negotiating period on country-specific US tariffs is set to expire on July 9, Trump enacts a multitude ...
Lazenby Group has secured investment to help it take a slice of the burgeoning self-service kiosk market, with the world's ...
Looking for sleep well at night stocks? Read about three stocks that could deliver strong return potential over the next five ...
3h
Zacks Investment Research on MSNIonis Beats on Q2 Earnings & Sales, Stock Up 5% on Raised '25 OutlookIonis Pharmaceuticals IONS reported second-quarter 2025 adjusted earnings per share (EPS) of 86 cents, significantly beating the Zacks Consensus Estimate of 27 cents. In the year-ago period, the ...
However, the business said on Thursday (July 31) the sale process had ended without a suitable offer being received. As a ...
SINGAPORE] Asia-Pacific could be the new frontier for biotechnology investment, a report by consulting firm Bain & Company ...
Pharmaceutical stocks are some of the biggest in the FTSE 100. The sector is threatened by tariffs, but some have posted encouraging results regardless.
London equities ended Wednesday narrowly mixed as investors weighed stronger-than-expected US economic data against a wave of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results